These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20048435)

  • 1. [Calcium antagonists: current and future applications based on new evidence. Calcium channel blockers and single-pill combination].
    Okura T; Higaki J
    Clin Calcium; 2010 Jan; 20(1):61-8. PubMed ID: 20048435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium antagonists: current and future applications based on new evidence. Combination antihypertensive therapy with calcium channel blockers].
    Ishimitsu T
    Clin Calcium; 2010 Jan; 20(1):52-60. PubMed ID: 20048434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-utility analysis of antihypertensive combination therapy in Japan by a Monte Carlo simulation model.
    Saito I; Kobayashi M; Matsushita Y; Mori A; Kawasugi K; Saruta T
    Hypertens Res; 2008 Jul; 31(7):1373-83. PubMed ID: 18957808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy.
    Oparil S; Weber M
    Postgrad Med; 2009 Mar; 121(2):25-39. PubMed ID: 19332960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of elderly hypertensive individuals with hyperlipidemia].
    Kozaki K
    Nihon Rinsho; 2005 Jun; 63(6):1061-6. PubMed ID: 15948391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens.
    Zeng F; Patel BV; Andrews L; Frech-Tamas F; Rudolph AE
    Curr Med Res Opin; 2010 Dec; 26(12):2877-87. PubMed ID: 21067459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
    Bramlage P
    Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system.
    de la Sierra A
    J Hum Hypertens; 2009 Aug; 23(8):503-11. PubMed ID: 19148104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE; Scott LJ
    Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination effect of calcium channel blocker and valsartan on cardiovascular event prevention in patients with high-risk hypertension: ancillary results of the KYOTO HEART Study.
    Sawada T; Yamada H; Shiraishi J; Kimura S; Matsubara H
    Clin Exp Hypertens; 2012; 34(2):153-9. PubMed ID: 22008090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CCB uptitration is superior to ARB uptitration in CKD patients who do not reach target blood pressure with ARB/CCB combined therapy].
    Ishii T; Kawamura T; Tsuboi N; Hosoya T
    Nihon Jinzo Gakkai Shi; 2010; 52(7):945-51. PubMed ID: 21077346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home.
    Hashimoto J; Hirayama H; Hanasawa T; Watabe D; Asayama K; Metoki H; Kikuya M; Ohkubo T; Totsune K; Imai Y
    Clin Exp Hypertens; 2005 May; 27(4):331-41. PubMed ID: 15921070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An overview of prophylactic therapy for migraine].
    Shimizu T
    Brain Nerve; 2009 Oct; 61(10):1107-15. PubMed ID: 19882936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The VALUE trial: a commentary.
    Sever P
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):99-101. PubMed ID: 15526243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension.
    Ishimitsu T; Numabe A; Masuda T; Akabane T; Okamura A; Minami J; Matsuoka H
    Hypertens Res; 2009 Nov; 32(11):962-8. PubMed ID: 19696778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.